Autosomal dominant polycystic kidney disease: modification of disease progression

被引:65
作者
Peters, DJM [1 ]
Breuning, MH [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Human & Clin Genet, NL-2333 AL Leiden, Netherlands
关键词
D O I
10.1016/S0140-6736(01)06531-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Autosomal dominant polycystic kidney disease is a common inherited disorder, which is characterised by the formation of fluid-filled cysts in both kidneys that leads to progressive renal failure. Mutations in two genes, PKD1 and PKD2, are associated with the disorder. We describe the various factors that cause variation in disease progression between patients. These include whether the patient has a germline mutation in the PKD1 or in the PKD2 gene, and the nature of the mutation. Detection of mutations in PKD1 is complicated, but the total number identified is rising and will enable genotype-to-phenotype studies. Another factor affecting disease progression is the occurrence of somatic mutations in PKD genes. Furthermore, modifying genes might directly affect the function of polycystins by affecting the rate of somatic mutations or the rate of protein interactions, or they might affect cystogenesis itself or clinical factors associated with disease progression. Finally, environmental factors that speed up or slow down progress towards chronic renal failure have been identified in rodents.
引用
收藏
页码:1439 / 1444
页数:6
相关论文
共 89 条
[1]   A family with a milder form of adult dominant polycystic kidney disease not linked to the PKD1 (16p) or PKD2 (4q) genes [J].
Ariza, M ;
Alvarez, V ;
Marin, R ;
Aguado, S ;
LopezLarrea, C ;
Alvarez, J ;
Menendez, MJ ;
Coto, E .
JOURNAL OF MEDICAL GENETICS, 1997, 34 (07) :587-589
[2]   Association of the angiotensin I converting enzyme gene deletion polymorphism with early onset of ESRF in PKD1 adult polycystic kidney disease [J].
Baboolal, K ;
Ravine, D ;
Daniels, J ;
Williams, N ;
Holmans, P ;
Coles, GA ;
Williams, JD .
KIDNEY INTERNATIONAL, 1997, 52 (03) :607-613
[3]  
BOGDANOVA N, 1995, HUM GENET, V95, P645
[4]   Human mitochondrial manganese superoxide dismutase polymorphic variant Ile58Thr reduces activity by destabilizing the tetrameric interface [J].
Borgstahl, GEO ;
Parge, HE ;
Hickey, MJ ;
Johnson, MJ ;
Boissinot, M ;
Hallewell, RA ;
Lepock, JR ;
Cabelli, DE ;
Tainer, JA .
BIOCHEMISTRY, 1996, 35 (14) :4287-4297
[5]   Loss of the polycystic kidney disease (PKD1) region of chromosome 16p13 in renal cyst cells supports a loss-of-function model for cyst pathogenesis [J].
Brasier, JL ;
Henske, EP .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (02) :194-199
[6]   DELETION OF THE TSC2 AND PKD1 GENES ASSOCIATED WITH SEVERE INFANTILE POLYCYSTIC KIDNEY-DISEASE - A CONTIGUOUS GENE SYNDROME [J].
BROOKCARTER, PT ;
PERAL, B ;
WARD, CJ ;
THOMPSON, P ;
HUGHES, J ;
MAHESHWAR, MM ;
NELLIST, M ;
GAMBLE, V ;
HARRIS, PC ;
SAMPSON, JR .
NATURE GENETICS, 1994, 8 (04) :328-332
[7]   Renoprotective effects of nitric oxide in angiotensin II-induced hypertension in the rat [J].
Chin, SY ;
Wang, CT ;
Majid, DSA ;
Navar, LG .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1998, 274 (05) :F876-F882
[8]  
Choukroun G, 1995, J AM SOC NEPHROL, V6, P1634
[9]   Modeling stochastic gene expression: Implications for haploinsufficiency [J].
Cook, DL ;
Gerber, LN ;
Tapscott, SJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) :15641-15646
[10]   EVIDENCE FOR A 3RD GENETIC-LOCUS FOR AUTOSOMAL-DOMINANT POLYCYSTIC KIDNEY-DISEASE [J].
DAOUST, MC ;
REYNOLDS, DM ;
BICHET, DG ;
SOMLO, S .
GENOMICS, 1995, 25 (03) :733-736